QuidelOrtho Corp. Stock
Price
Target price
€41.80
€41.80
1.450%
0.6
1.450%
€56.55
17.09.24 / Tradegate
WKN: A3DNGX / Symbol: QDEL / Name: QuidelOrtho / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
QuidelOrtho Corp. Stock
There is an upward development for QuidelOrtho Corp. compared to yesterday, with an increase of €0.60 (1.450%).
With 8 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 56 € shows a positive potential of 33.97% compared to the current price of 41.8 € for QuidelOrtho Corp..
For the coming years our community has positive and negative things to say abot the QuidelOrtho Corp. stock. Criterium "Innovation" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of QuidelOrtho Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| QuidelOrtho Corp. | 1.450% | 2.451% | 2.956% | -41.060% | -38.366% | -68.018% | -27.355% |
| Illumina Inc. | -0.480% | 5.577% | -1.746% | -8.497% | -6.304% | -68.407% | -56.424% |
| Waters Corp. | 1.170% | 1.847% | -1.206% | 16.615% | 0.397% | -10.296% | 46.793% |
| Boston Scientific | 0.670% | -1.316% | 5.634% | 51.057% | 45.801% | 98.308% | 92.901% |
Comments
QuidelOrtho Co. (NASDAQ: QDEL) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $57.00 price target on the stock, up previously from $40.00.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $61.00 price target on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $61.00 price target on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
News
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
QuidelOrtho Corporation (Nasdaq: QDEL) is pleased to announce the appointment of Lee Bowman as Chief Human Resources Officer (CHRO). In this pivotal role, Bowman leads QuidelOrtho’s human resources
Why QuidelOrtho Stock Blasted 10% Higher Today
Sometimes, all a stock needs to have a good day on Wall Street is a positive note from one of the analysts tracking it. This dynamic was in evidence on Thursday with QuidelOrtho (NASDAQ: QDEL), when
VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”) has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its VITROS syphilis assay as part of its menu, strengthening